References
- Scott B. C., Aruoma O. I., Evans P. J., O'Neil C., Van der Vliet A., Cross C. E., Tritschler H., Halliwell B. Lipoic and dihydrolipoic acids as antioxidants a critical evaluation. Free Radic. Res. 1994; 20: 119–133
- Heitzer T., Finck B., Albers S., Krohn K., Kohlschutter A., Meinertz T. Beneficial effects of alpha‐lipoic acid and ascorbic acid on endothelium‐dependent, nitric oxide‐mediated vasodilatation in diabetic patients: relation to parameters of oxidative stress. Free Radic. Biol. Med. 2001; 31: 53–61
- Melhem M. F., Craven P. A., Derubertis F. R. Effects of dietary supplementation of alpha‐lipoic acid on early glomerular injury in diabetes mellitus. J. Am. Soc. Nephrol. 2001; 12: 124–133
- Jacob S., Streeper R. S., Fogt D. L., Hokama J. Y., Tritschler H. J., Dietze G. J., Henriksen E. J. The antioxidant α‐lipoic acid enhances insulin‐stimulated glucose metabolism in insulin‐resistant rat skeletal muscle. Diabetes 1996; 45: 1024–1029
- Jacob S., Henriksen E. J., Tritschler H. J., Augustin H. J., Dietze G. J. Improvement of insulin‐stimulated glucose disposal in type II diabetes after repeated parenteral administration of thioctic acid. Exp. Clin. Endocrinol. Diabetes 1996; 104: 284–288
- Teichert J., Kern J., Tritschler H.‐J., Ulrich H., Preiss R. Investigations on the pharmacokinetics of α‐lipoic acid in healthy volunteers. Int. J. Clin. Pharmacol. Ther. 1998; 36: 625–628
- Bernkop‐Schnürch A., Schuhbauer H., Clausen A. E., Hanel R. Development of a sustained release dosage form for α‐lipoic acid—part 1: design and in vitro evaluation. Drug Dev. Ind. Pharm. 2004; 30: 27–34
- Lorenzo‐Lamosa M. L., Remunan‐Lopez C., Vila‐Jato J. L., Alonso M. J. Design of microencapsulated chitosan microspheres for colonic drug delivery. J. Control. Release 1998; 52: 109–118
- Tozaki H., Fujita T., Odoriba T., Terabe A., Suzuki T., Tanaka C., Okabe S., Muranishi S., Yamamoto A. Colon‐specific delivery of R68070, a new thromboxane synthase inhibitor, using chitosan capsules: therapeutic effects against 2,4,6‐trinitrobenzene sulfonic acid‐induced ulcerative colitis in rats. Life Sci. 1999; 64: 1155–1162
- Tozaki H., Komoike J., Tada C., Maruyama T., Terabe A., Suzuki T., Yamamoto A., Muranishi S. Chitosan capsules for colon‐specific drug delivery: improvement of insulin absorption from the rat colon. J. Pharm. Sci. 1997; 86: 1016–1021
- Snyder H. R., Stewart J. M., Allen R. E., Dearborn R. J. The mechanism of modifier action in the GR‐S polymerization, I. J. Am. Chem. Soc. 1946; 68: 1422–1428
- Niebich G., Büchele B., Blome J., Grieb S., Brandt G., Kampa P., Raffel H. H., Locher M., Borbe H. O., Nubert I., Fleischhauer I. Enantioselective high‐performance liquid chromatography assay of (+)R‐and (−)S‐alpha‐lipoic acid in human plasma. Chirality 1997; 9: 32–36
- Coupe A. J., Davis S. S., Wilding I. R. Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm. Res. 1991; 8: 360–364
- Macleod G. S., Fell J. T., Collett J. H., Sharma H. L., Smith A. M. Selective drug delivery to the colon using pectin:chitosan:hydroxypropyl methylcellulose film coated tablets. Int. J. Pharm. 1999; 187: 251–257
- Peter G., Borbe H. O. Absorption of [7,8 − 14C]rac‐α‐lipoic acid from in situ ligated segments of the gastrointestinal tract of the rat. Arzneim.‐Forsch. 1995; 45: 293–299
- Streeper R. S., Henriksen E. J., Jacob S., Hokama J. Y., Fogt D. L., Tritschler H. J. Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin‐resistant skeletal muscle. Am. J. Physiol. 1997; 273: 185–191
- Khamaisi M., Potashnik R., Tirosh A., Demshchak E., Rudich A., Tritschler H., Wessel K., Bashan N. Lipoic acid reduces glycemia and increases muscle GLUT4 content in streptozotocin‐diabetic rats. Metabolism 1997; 46: 763–768
- Black K., Qu X., Seale J. P., Donnelly R. Metabolic effects of thioctic acid in rodent models of insulin resistance and diabetes. Clin. Exp. Pharmacol. Physiol. 1998; 25: 712–714